Insights

Providing the latest information from our experts at Forge
April, 3 2023 in
Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography Platform

Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography...

December, 1 2022 in
Streamline the AAV Manufacturing Process with High-Grade Starting Materials

 Streamline the AAV Manufacturing Process with High-Grade Starting Materials Authors:

November, 3 2022 in
What the DMF! Spotlight on Forge's Drug Master File

Gene therapy developers' Investigational New Drug (IND) application process is arduous...

August, 12 2022 in
Addressing the ‘Capacity Crunch’ with a Scalable Platform Process Approach

Authors: Brianna Barrett, Ph.D., Associate Director, Technical Sales, Forge Biologics ...

February, 11 2022 in
Women Forging Change

At Forge, we believe wholeheartedly that people are our greatest asset. February 11th is...